Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Oct 15 - Oct 20
If youre unsure which option is best for your unique needs, were here to help
Dowling LR, Strazzari MR, Keely S, Kaiko GE
These preclinical findings support clinical trial results showing that tirzepatide, a dual GIPR/GLP-1R agonist, exhibits greater anti-obesity effects than GLP-1 receptor agonists alone
Individual results vary, and no treatment guarantees specific weight-loss outcomes
Rekha Kumar , MD, is a board-certified endocrinologist and obesity medicine specialist and head of medical affairs at Found Health
US$ 22.67
US$ 21.22
US$ 28.22
US$ 28.50
US$ 27.43
US$ 20.63
US$ 27.15
US$ 26.43
US$ 22.41
